title: Abnormalities of B cell activation and immunoregulation in patients with chronic inflammatory liver diseases.
abstract: The immunoglobulin production capacities of peripheral blood lymphocytes obtained from patients with various chronic inflammatory liver diseases and from normal individuals were compared. Using a reverse hemolytic plaque assay, immunoglobulin-secreting cells (ISC) were counted immediately after isolation (immediate ISC) and again after 6-day, in vitro cultivation without stimulant (spontaneous ISC) or in the presence of pokeweed mitogen, PWM (PWM-induced ISC). An increased number of immediate ISC were observed in patients with chronic active hepatitis (CAH) of the autoimmune type (n = 7) or with CAH type B (n = 32), probably reflecting a defect of the in vivo suppressor cell system as previously demonstrated. In vitro preincubation of cells with 5 x 10(-8) M prednisolone reduced the increase in the number of immediate ISC in patients with CAH of the autoimmune type. On the other hand, lymphocytes obtained from patients with CAH-type NANB (n = 9) and with primary biliary cirrhosis (PBC) (n = 12) showed an impaired capacity to generate ISC upon stimulation with PWM. Spontaneous ISC from patients' lymphocytes were not significantly different from those of normal individuals. Using allogeneic co-cultures with lymphocytes from normal individuals and from patients with CAH NANB hepatitis or primary biliary cirrhosis, we observed no increase in suppressor cell activity. Therefore, the diminished responses to PWM are probably attributable to an alteration in the peripheral helper T-cell compartment.
authors.affiliation: Abteilung für Innere Medizin mit Schwerpunkt Hämatologie-Onkologie, Klinikum Steglitz, Berlin, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Sieber
authors.forename: J V
authors.initials: JV
authors.lastname: Teichmann
authors.forename: B
authors.initials: B
authors.lastname: Möller
authors.forename: U
authors.initials: U
authors.lastname: Hopf
mesh_terms: D000917:Antibody Formation / Q000187:drug effects; D001327:Autoimmune Diseases / Q000276:immunology / Q000473:pathology; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology*; D002478:Cells, Cultured; D006462:Hemolytic Plaque Technique; D006521:Hepatitis, Chronic / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007249:Inflammation; D008105:Liver Cirrhosis, Biliary / Q000276:immunology* / Q000473:pathology; D008213:Lymphocyte Activation / Q000187:drug effects; D011043:Pokeweed Mitogens / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology
chemical_list: D011043:Pokeweed Mitogens; D011239:Prednisolone